Across TCGA pan-cancer cohorts, ANG Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ANG data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ANG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANG expression acts as an unfavorable survival marker.

STAD, HNSC, and UCEC are the cancer types where ANG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.184	0.730	.001	33	view →
HNSC	DFS	Median	All	0.180	0.710	.009	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ANG tumor-vs-normal RNA expression · all ANG data types